Human IL-33 重组人白细胞介素-33(人白介素-33)(90123ES)
HiActi®细胞因子品牌故事|
选购指南|
使用指南|
产品应用
IL-33, also known as NF-HEV and DVS 27, is a 30 kDa proinflammatory protein that may also regulate gene transcription. DVS 27 was identifed as a gene that is upregulated in vasospastic cerebral arteries. NFHEV was described as a nuclear factor that is preferentially expressed in the endothelial cells of high endothelial venules relative to endothelial cells from other tissues. IL?33 was identified based on sequence and structural homology with IL?1 family cytokines. DVS 27, NF?HEV, and IL?33 share 100% amino acid sequence identity. IL?33 is constitutively expressed in smooth muscle and airway epithelia. It is up-regulated in arterial smooth muscle, dermal fibroblasts, and keratinocytes following IL?1 alpha or IL?1 beta stimulation. Similar to IL, IL33 can be cleaved in vitro by caspase, generating an Nterminal fragment that is slightly shorter than the Cterminal fragment. The N?terminal portion of full length IL?33 contains a predicted bipartite nuclear localization sequence and a homeodomain?like helix?turn?helix DNA binding domain. By immunofluorescence, full length IL33 localizes to the nucleus in HUVECs and transfectants. The Cterminal fragment, corresponding to mature IL?33, binds and triggers signaling through mast cell IL?1 R4/ST2L, a longtime orphan receptor involved in the augmentation of Th2 cell responses. A ternary signaling complex is formed by the subsequent association of IL33 and ST2L with IL?1R AcP . Stimulation of Th2 polarized lymphocytes with mature IL33 in vitro induces IL?5 and IL?13 secretion. In vivo administration of mature IL?33 promotes increased production of IL5, IL13, IgE, and IgA, as well as splenomegaly and inflammatory infiltration of mucosal tissues . Full length and mature human IL?33 share 52?58% aa sequence identity with mouse and rat IL?33. Human IL?33 shares less than 20% aa sequence identity with other IL?1 family proteins.
高纯度、高活性、低内毒素、高批间一致性
-25 ~ -15℃保存,收到货之后有效期1年。 复溶后,无菌条件下,-85 ~ -65℃保存,3个月有效期。
【选购指南】细胞培养HiActi®细胞因子系列产品选购指南
19193
2026-04-14
【选购指南】细胞因子系列产品专题汇总选购指南
15614
2026-04-14
【选购指南】翌圣生物HiActi®细胞因子产品使用指南
458
2026-09-22
【技术讲解】细胞因子科学选型--内毒素
15398
2026-09-21
【技术讲解】细胞因子科学选型--活性
9939
2026-09-21
【技术讲解】细胞因子科学选型--载体蛋白
19214
2026-09-21
【技术讲解】细胞因子科学选型--常见问题解答
11493
2026-09-21
【技术讲解】细胞因子科学选型--纯度
15997
2026-09-21
【技术讲解】细胞因子科学选型--不同种属来源
12171
2026-09-21
【技术讲解】细胞因子科学选型--不同表达系统来源
19568
2026-09-21
【技术讲解】细胞因子科学选型--不同标签
20900
2026-09-21
【技术讲解】细胞因子科学选型--冻干保护剂
16588
2026-09-21
【文献解读】定量试剂相关发表文献
19159
2026-06-05





